openPR Logo
Press release

Anti Diarrheal Drugs Market | Analysis & Key Trends 2024

07-20-2017 11:17 PM CET | Health & Medicine

Press release from: Transparency Market Research - Pharmaceutical

Anti Diarrheal Drugs Market | Analysis & Key Trends 2024

Global Anti Diarrheal Drugs Market: Overview

Diarrhea is referred to as a condition marked by frequent, loose watery stools. Anti diarrheal drugs are used to treat sudden diarrhea and possess the mechanism of slowing down the movement of the gut. This helps to reduce the number of bowel movements and also make the stools less watery. It is referred to as chronic diarrhea if it lasts for more than two weeks. Various causes of diarrhea can be a virus such as rotavirus, hepatitis, bacterium such as E. coli, Shigella and parasites such as those causing amoebiasis and giardiasis. Anti diarrheal drugs also help in treating the ongoing diarrhea in people with inflammatory bowel disease. Some drugs help in reducing the amount of discharge in patients with ileostomy. Several nonmedical conditions can also cause diarrhea. These include indigestion, surgery such as removal of gall bladder, certain tumors, and inflammation in the intestinal tract, amongst others. Symptoms of diarrhea include abdominal bloating, cramps, nausea, vomiting, watery stools, and sometimes weight loss, fever and presence of blood or mucus in the stools. Clinical types of diarrhea are acute watery diarrhea, acute bloody diarrhea and persistent diarrhea.

Most of the episodes of diarrhea are known to resolve with simple dietary modifications and may not require treatment. However, in case of severe diarrhea, laboratory evaluation is required which includes blood tests, and stool specimen evaluation to identify the type of diarrhea. Endoscopic examinations help in detecting the etiology of chronic diarrhea. Various other diagnostic tests include double balloon enteroscopy, capsule endoscopy, radiographic studies such as ultrasound and CT scan.

View Report –
http://www.transparencymarketresearch.com/anti-diarrheal-drugs-market.html

Global Anti Diarrheal Drugs Market: Segmentation

The global anti diarrheal drugs market can be segmented based on drug class, brand and geography. Drug class segments of the market are mucosal protectants and adsorbents such as kaolin-pectin and activated charcoal, motility modifying drugs such as anticholinergics and opiates, antimicrobial therapy, non steroidal anti-inflammatory drugs and anti toxins. Over-the-counter anti diarrheal drugs include Pepto-Bismol, Imodium A-D, Kaopectate, and others. Anti-mobility agents such as Loperamide are the most commonly used drug class to treat chronic diarrhea.

Geographically, the global anti diarrheal drugs market can be segmented into four major regions, namely North America, Europe, Asia-Pacific and Rest of the World. Acute diarrhea is one of the most commonly reported illnesses in the United States. According to the WHO, diarrhea is the second leading cause of death, especially in children less than 5 years of age. Prevention of the diarrheal disease can be achieved by drinking of safe water coupled with adequate hygiene and sanitation. Higher prevalence rates of diarrheal disease in developing countries have been observed due to unhygienic and improper sanitation procedures. Moreover, diarrhea is known to be a major cause of malnutrition in children, since the disease deprives the child of the nutrition required for their proper growth. Various other measures undertaken to treat the diarrheal disease include rehydration therapies, administration of zinc supplements, nutrient rich food coupled with consultation by health professional.

Introduction of anti diarrheal drugs for HIV/AIDS such as Fulyzaq (crofelemer) by Glenmark Pharmaceuticals are expected to drive the growth of the market in the near future. Anti diarrheal help in controlling severe symptoms however are contra-indicated in patients with fever or bloody diarrhea. Various side effects associated with anti-diarrheal drugs include mouth dryness, dizziness and drowsiness. Certain severe side effects may include stomach pain, vomiting, constipation, nausea and decrease in appetite. Key players contributing to the global anti diarrheal drugs market include Actelion, Lupin, GSK, Glenmark Pharmaceuticals, Perrigo, and Pfizer, Inc.

Request a brochure of this report to know what opportunities will emerge in the rapidly evolving Anti Diarrheal Drugs Market during 2016- 2024
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=12215

About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Anti Diarrheal Drugs Market | Analysis & Key Trends 2024 here

News-ID: 634934 • Views:

More Releases from Transparency Market Research - Pharmaceutical

Neurovascular Devices Market Business Opportunities and Growth Challenges Report
Neurovascular Devices Market Business Opportunities and Growth Challenges Report
Global Neurovascular Devices Market: Overview The global population is aging rapidly. According to WHO, the chances of health risks are greater in geriatric people than the young generation. Old age is considered to be one of the biggest risk factors that are responsible for developing various diseases such as cardiovascular and neurological conditions. It is because of these factors, the global neurovascular devices market is experiencing robust growth in the
Pneumococcal Vaccines Market anticipated expand at a CAGR of 3.3% from 2018 to 2026
Pneumococcal Vaccines Market anticipated expand at a CAGR of 3.3% from 2018 to 2 …
Transparency Market Research (TMR) has published a new report titled, “Pneumococcal Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”. According to the report, the global pneumococcal vaccines market was valued at US$ 7,247.6 Mn in 2017 and is anticipated expand at a CAGR of 3.3% from 2018 to 2026. Increase in patient pool, growth of the pharmaceutical industry, government initiatives to increase vaccination programs, rise
Swab and Viral Transport Medium Market projected to expand at a CAGR of ~3% from 2020 to 2030
Swab and Viral Transport Medium Market projected to expand at a CAGR of ~3% from …
Swab and Viral Transport Medium Market: Introduction Transparency Market Research has published a new report titled, ‘Global Swab and Viral Transport Medium Market ’. According to the report, the global swab and viral transport medium market was valued at US$ 0.9 Bn in 2019 and is projected to expand at a CAGR of ~3% from 2020 to 2030. Viral transport medium (VTM) enables safe transfer of viruses, chlamydia, and mycoplasma for
Radiofrequency Ablation Devices Market by Product, Geography and Forecast to 202 …
Transparency Market Research (TMR) has published a new report titled, 'Radiofrequency Ablation Devices for Pain Management Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019-2027'. According to the report, the global radiofrequency ablation devices for pain management market was valued at US$ 543.0 Mn in 2018 and is projected to expand at a CAGR of above 11.0% from 2019 to 2027. Overview Radiofrequency ablation is a minimally invasive surgical

All 5 Releases


More Releases for Anti

Sleeplab Anti-Snore Reviews: Best Anti Snore Chin Strap?
if you and your partner share the same bed, snoring can be a bad habit. People who snore don't know how annoying it is to others who are around them. If you want to get rid of this, you need a gadget that can massage your throat and stop you from snoring at the same time. Almost half of adults snore while asleep. People who are overweight are more likely to
Anti-Venom Market Report 2018: Segmentation by Anti-Venom Type (Monovalent, Poly …
Global Anti-Venom market research report provides company profile for CSL Behring, Bharat Serums and Vaccines Ltd., Haffkine Bio-Pharmaceutical Corporation Ltd, Vacsera, Vins Bioproducts Limited, Rare Therapeutics and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025,
Anti-Suicide Drugs Market Report 2018: Segmentation by Chemistry Type (Anti-Depr …
Global Anti-Suicide Drugs market research report provides company profile for Pfizer, Inc., AstraZeneca plc, Eli Lilly and Company, Allergan plc, GlaxoSmithKline plc, Merck & Co., Inc., H. Lundbeck A/S, NeuroRx, Inc., Johnson & Johnson and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate,
Top Leading Vendors of “Anti-Aging Products and Services Market” by product …
Axiom Market Research & Consulting added a latest report on ‘Global Anti-aging Products and Services Market, By Services, Devices, Products, Demographics, End Users and Geography – Global Market Share, Trend Analysis & Forecast Up To 2024’ The global anti-aging products and services market is anticipated to develop at a CAGR of 4.23% from 2019 to 2024. The market is revised for its services, such as anti-pigmentation therapy, adult acne therapy,
Anti-microbial/Anti-fungal Tests Market
Microbial and fungal infections are a major cause of death globally and can even cause potential epidemics, creating a huge economic burden on countries, especially developing ones. To nip the spread of such infections in the bud, prevention is a far better solution than cure - accomplished by isolating infected cases and carrying out primary screening tests. Future Market Insights in its report titled ‘Anti-microbial/Anti-fungal Tests Market: Global Industry Analysis
Anti-venom Market, by Anti-venom Type (Polyvalent, Monovalent),
Anti-venom is a medication majorly used to treat snake bites and it can also be used to treat bites from scorpions, spiders or other reptiles. It is made by fractionating the blood of the donor (horse or sheep), which is hyper immunized with snake venom. These products are available in either lyophilized or liquid forms. Anti-venom is the only effective therapy against snake bites and apart from lifesaving, they